Xue‐Mei You
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 19
- Hepatitis C virus research 3
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 5
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 6
-
- Cancer Mechanisms and Therapy 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
-
- Lung Cancer Treatments and Mutations 3
- Partner nations
- ChinaItalyUnited States
In The Last Decade
Xue‐Mei You
40 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 485
- Epidemiology 421
- Cancer Research 160
- Oncology 196
- Pathology and Forensic Medicine 93
Countries citing papers authored by Xue‐Mei You
This map shows the geographic impact of Xue‐Mei You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Mei You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Mei You more than expected).
Fields of papers citing papers by Xue‐Mei You
This network shows the impact of papers produced by Xue‐Mei You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Mei You. The network helps show where Xue‐Mei You may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue‐Mei You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort studybreakdown → | 2024 | 87 |
| 2 | 2023 | 70 | |
| 3 | 2022 | 6 | |
| 4 | 2020 | 71 | |
| 5 | 2018 | 40 | |
| 6 | 2017 | 10 | |
| 7 | 2017 | 13 | |
| 8 | 2017 | 25 | |
| 9 | 2017 | 20 | |
| 10 | 2016 | 39 | |
| 11 | 2016 | 4 | |
| 12 | 2016 | 2 | |
| 13 | 2016 | 10 | |
| 14 | 2015 | 13 | |
| 15 | 2014 | 43 | |
| 16 | 2013 | 13 | |
| 17 | 2012 | 0 | |
| 18 | 2012 | 45 | |
| 19 | 2010 | 2 | |
| 20 | 2009 | 1 |
About Xue‐Mei You
Xue‐Mei You is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Cancer, Lipids, and Metabolism (6 papers), Hepatitis B Virus Studies (5 papers), Cancer Mechanisms and Therapy (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Hepatology (485 citations), Epidemiology (421 citations) and Cancer Research (160 citations). Xue‐Mei You has collaborated with scholars based in China, Italy and United States. Frequent co-authors include Jian‐Hong Zhong, Liang Ma, Bang‐De Xiang, Rong‐Rui Huo, Le‐Qun Li, Le‐Qun Li, Lu Zhai, Qian Liao, Yanyan Wang and Wen‐Feng Gong.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.